Biomagnetics Confirms Conference Call Hosted by
President Clayton Hardman
August 26, 2010 07:34 PM Eastern Daylight Time
SAN FRANCISCO--(EON: Enhanced Online News)--Biomagnetics Diagnostics Corp. (PINK SHEETS:BMGP -
News), a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria
detection, confirms a scheduled conference call with the President and CEO of Biomagnetics Diagnostics Corp for
Friday the 27th of August at 8:00 am PST and will conclude by 9:00am PST
The conference call will begin at 8:00am PST.All interested parties can participate by dialing telephone
number: 1-877-278-9680 and inputting conference ID 96645592.
It is recommended to all participates, prior to calling in, that they view the video created by the scientific team of Dr.
Basil Swanson and Dr. Harshini Mukundan at Los Alamos National laboratories. This video is on the Integrated
Optical Biosensor (IOBS) development. Please see the link below to access video.
Clayton Hardman, CEO of Biomagnetics Diagnostics states, “We are excited for everyone to see the progress and
technology we are dealing with and have it presented by the development team. I also hope to take this time to
answer questions from the community that has supported and is engaged in our success.”
Biomagnetics has entered into a patent license Agreement and Collaborative research and Development Agreement
(CRADA) with Los Alamos National Security, LLC. Under the agreements, Biomagnetics will have access to the
IOBS technology. Our initial focus will be on tuberculosis, cholera and malaria diagnosis.
About Biomagnetics Diagnostics Corp.
Biomagnetics Diagnostics Corporation is an advanced medical device and biotechnology company. The Company’s
revolutionary diagnostic systems, which are based on advanced magnetic, test for any viral or bacterial disease using
any body fluid. The Company's technology allows laboratories to perform far more tests in the same amount of